A PD Solution to Protect Peritoneal Membranes

PD-protec® by Zytoprotec, which now has FDA orphan drug status, is in Phase III trials among 300 patients in the US and Europe. The product aims to reduce PD complications such as peritonitis and membrane failure.

Read the full article » | Posted 01/11/2018

Related Articles